Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

Macrophage centripetal migration drives spontaneous healing process after spinal cord injury.

Kobayakawa K, Ohkawa Y, Yoshizaki S, Tamaru T, Saito T, Kijima K, Yokota K, Hara M, Kubota K, Matsumoto Y, Harimaya K, Ozato K, Masuda T, Tsuda M, Tamura T, Inoue K, Edgerton VR, Iwamoto Y, Nakashima Y, Okada S.

Sci Adv. 2019 May 15;5(5):eaav5086. doi: 10.1126/sciadv.aav5086. eCollection 2019 May.

2.

The acute phase serum zinc concentration is a reliable biomarker for predicting the functional outcome after spinal cord injury.

Kijima K, Kubota K, Hara M, Kobayakawa K, Yokota K, Saito T, Yoshizaki S, Maeda T, Konno D, Matsumoto Y, Nakashima Y, Okada S.

EBioMedicine. 2019 Mar;41:659-669. doi: 10.1016/j.ebiom.2019.03.003. Epub 2019 Mar 20.

3.

Genome-wide analyses reveal genes subject to positive selection in Toxoplasma gondii.

Yoshizaki S, Akahori H, Umemura T, Terada T, Takashima Y, Muto Y.

Gene. 2019 May 30;699:73-79. doi: 10.1016/j.gene.2019.03.008. Epub 2019 Mar 9.

PMID:
30858136
4.

Current status of hepatitis E virus infection at a rhesus monkey farm in China.

Yang F, Duan S, Guo Y, Li Y, Yoshizaki S, Takeda N, Wakita T, Muramatsu M, Zhao Y, He Z, Li TC.

Vet Microbiol. 2019 Mar;230:244-248. doi: 10.1016/j.vetmic.2019.01.021. Epub 2019 Feb 13.

PMID:
30827396
5.

Genotype 5 Hepatitis E Virus Produced by a Reverse Genetics System Has the Potential for Zoonotic Infection.

Li TC, Bai H, Yoshizaki S, Ami Y, Suzaki Y, Doan YH, Takahashi K, Mishiro S, Takeda N, Wakita T.

Hepatol Commun. 2018 Nov 30;3(1):160-172. doi: 10.1002/hep4.1288. eCollection 2019 Jan.

6.

Detection of Subgenotype IA and IIIA Hepatitis A Viruses in Rivers Flowing through Metro Manila, the Philippines.

Bai H, Shiota T, Yoshizaki S, Saito-Obata M, Malbas FF Jr, Lupisan SP, Oshitani H, Takeda N, Muramatsu M, Wakita T, Ishii K, Li TC.

Jpn J Infect Dis. 2019 Jan 23;72(1):53-55. doi: 10.7883/yoken.JJID.2018.148. Epub 2018 Aug 31.

7.

Periostin Promotes Fibroblast Migration and Inhibits Muscle Repair After Skeletal Muscle Injury.

Hara M, Yokota K, Saito T, Kobayakawa K, Kijima K, Yoshizaki S, Okazaki K, Yoshida S, Matsumoto Y, Harimaya K, Nakashima Y, Okada S.

J Bone Joint Surg Am. 2018 Aug 15;100(16):e108. doi: 10.2106/JBJS.17.01230.

PMID:
30106825
8.

Multiple antiviral activities of the antimalarial and anti-hepatitis C drug candidates N-89 and N-251.

Ueda Y, Gu W, Dansako H, Kim HS, Yoshizaki S, Okumura N, Ishikawa T, Nishitsuji H, Kato F, Hishiki T, Satoh S, Ishii K, Masuda M, Shimotohno K, Ikeda M, Kato N.

Biochem Biophys Rep. 2018 Jun 1;15:1-6. doi: 10.1016/j.bbrep.2018.05.007. eCollection 2018 Sep.

9.

Evaluation of Heating Conditions for Inactivation of Hepatitis E Virus Genotypes 3 and 4.

Imagawa T, Sugiyama R, Shiota T, Li TC, Yoshizaki S, Wakita T, Ishii K.

J Food Prot. 2018 Jun;81(6):947-952. doi: 10.4315/0362-028X.JFP-17-290.

PMID:
29745758
10.

Formal Lossen Rearrangement/[3+2] Annulation Cascade Catalyzed by a Modified Cyclopentadienyl RhIII Complex.

Yamada T, Shibata Y, Kawauchi S, Yoshizaki S, Tanaka K.

Chemistry. 2018 Apr 17;24(22):5723-5727. doi: 10.1002/chem.201801125. Epub 2018 Apr 10.

PMID:
29516563
11.

Macrophage Infiltration Is a Causative Factor for Ligamentum Flavum Hypertrophy through the Activation of Collagen Production in Fibroblasts.

Saito T, Hara M, Kumamaru H, Kobayakawa K, Yokota K, Kijima K, Yoshizaki S, Harimaya K, Matsumoto Y, Kawaguchi K, Hayashida M, Inagaki Y, Shiba K, Nakashima Y, Okada S.

Am J Pathol. 2017 Dec;187(12):2831-2840. doi: 10.1016/j.ajpath.2017.08.020. Epub 2017 Sep 19.

12.

Determination of Ferret Enteric Coronavirus Genome in Laboratory Ferrets.

Li TC, Yoshizaki S, Kataoka M, Doan YH, Ami Y, Suzaki Y, Nakamura T, Takeda N, Wakita T.

Emerg Infect Dis. 2017 Sep;23(9):1568-1570. doi: 10.3201/eid2309.160215.

13.

Interaction of reactive astrocytes with type I collagen induces astrocytic scar formation through the integrin-N-cadherin pathway after spinal cord injury.

Hara M, Kobayakawa K, Ohkawa Y, Kumamaru H, Yokota K, Saito T, Kijima K, Yoshizaki S, Harimaya K, Nakashima Y, Okada S.

Nat Med. 2017 Jul;23(7):818-828. doi: 10.1038/nm.4354. Epub 2017 Jun 19.

PMID:
28628111
14.

Serological evidence of hepatitis E virus infection in dromedary camels in Ethiopia.

Li TC, Yoshizaki S, Zhou X, Sentsui H, Shirato K, Matsuyama S, Melaku SK, Bazartseren B, Takeda N, Wakita T.

J Virol Methods. 2017 Aug;246:34-37. doi: 10.1016/j.jviromet.2017.04.008. Epub 2017 Apr 21.

PMID:
28438608
15.

Genetic and physicochemical analyses of a novel ferret hepatitis E virus, and clinical signs of infection after birth.

Li TC, Yoshizaki S, Kataoka M, Ami Y, Suzaki Y, Doan YH, Haga K, Ishii K, Takeda N, Wakita T.

Infect Genet Evol. 2017 Jul;51:153-159. doi: 10.1016/j.meegid.2017.03.026. Epub 2017 Mar 25.

PMID:
28347753
16.

Fulvene Synthesis by Rhodium(I)-Catalyzed [2+2+1] Cycloaddition: Synthesis and Catalytic Activity of Tunable Cyclopentadienyl Rhodium(III) Complexes with Pendant Amides.

Yoshizaki S, Shibata Y, Tanaka K.

Angew Chem Int Ed Engl. 2017 Mar 20;56(13):3590-3593. doi: 10.1002/anie.201612590. Epub 2017 Feb 20.

PMID:
28218799
17.

An Outbreak of Acute Hepatitis Caused by Genotype IB Hepatitis A Viruses Contaminating the Water Supply in Thailand.

Ruchusatsawat K, Wongpiyabovorn J, Kawidam C, Thiemsing L, Sangkitporn S, Yoshizaki S, Tatsumi M, Takeda N, Ishii K.

Intervirology. 2016;59(4):197-203. doi: 10.1159/000455856. Epub 2017 Feb 17.

18.

Primary extradural malignant melanoma of the spine: A case report.

Yoshizaki S, Inokuchi A, Hamada T, Nishida K, Imamura R, Nakahara H, Komatsu T, Arizono T.

J Orthop Sci. 2017 Feb 4. pii: S0949-2658(17)30012-X. doi: 10.1016/j.jos.2017.01.007. [Epub ahead of print] No abstract available.

PMID:
28173987
19.

No Evidence of Rat Hepatitis E Virus Excretion in Urine Samples of Rats.

Li TC, Yoshizaki S, Ami Y, Suzaki Y, Johne R, Wakita T.

Jpn J Infect Dis. 2017 May 24;70(3):305-307. doi: 10.7883/yoken.JJID.2016.283. Epub 2016 Aug 31.

20.

Production of infectious dromedary camel hepatitis E virus by a reverse genetic system: Potential for zoonotic infection.

Li TC, Zhou X, Yoshizaki S, Ami Y, Suzaki Y, Nakamura T, Takeda N, Wakita T.

J Hepatol. 2016 Dec;65(6):1104-1111. doi: 10.1016/j.jhep.2016.07.013. Epub 2016 Jul 19.

PMID:
27449916
21.

Clinical Features and Transmission Pattern of Hepatitis A: An Experience from a Hepatitis A Outbreak Caused by Two Cocirculating Genotypes in Sri Lanka.

Dahanayaka NJ, Kiyohara T, Agampodi SB, Samaraweera PK, Kulasooriya GK, Ranasinghe JC, Semage SN, Yoshizaki S, Wakita T, Ishii K.

Am J Trop Med Hyg. 2016 Oct 5;95(4):908-914. Epub 2016 Jul 5.

22.

Ferret hepatitis E virus infection induces acute hepatitis and persistent infection in ferrets.

Li TC, Yang T, Yoshizaki S, Ami Y, Suzaki Y, Ishii K, Kishida N, Shirakura M, Asanuma H, Takeda N, Wakita T.

Vet Microbiol. 2016 Feb 1;183:30-6. doi: 10.1016/j.vetmic.2015.11.014. Epub 2015 Nov 26.

PMID:
26790932
23.

Production of infectious ferret hepatitis E virus in a human hepatocarcinoma cell line PLC/PRF/5.

Li TC, Yoshizaki S, Yang T, Kataoka M, Nakamura T, Ami Y, Yuriko S, Takeda N, Wakita T.

Virus Res. 2016 Feb 2;213:283-288. doi: 10.1016/j.virusres.2015.11.027. Epub 2016 Jan 4.

PMID:
26763355
24.

Rhodium-Catalyzed Asymmetric [2 + 2 + 2] Cycloaddition of 1,6-Enynes with Cyclopropylideneacetamides.

Yoshizaki S, Nakamura Y, Masutomi K, Yoshida T, Noguchi K, Shibata Y, Tanaka K.

Org Lett. 2016 Feb 5;18(3):388-91. doi: 10.1021/acs.orglett.5b03387. Epub 2016 Jan 12.

PMID:
26756430
25.

Molecular Evolution of the TET Gene Family in Mammals.

Akahori H, Guindon S, Yoshizaki S, Muto Y.

Int J Mol Sci. 2015 Dec 1;16(12):28472-85. doi: 10.3390/ijms161226110.

26.

Rapid Synthesis of Thiophene-Based, Organic Dyes for Dye-Sensitized Solar Cells (DSSCs) by a One-Pot, Four-Component Coupling Approach.

Matsumura K, Yoshizaki S, Maitani MM, Wada Y, Ogomi Y, Hayase S, Kaiho T, Fuse S, Tanaka H, Takahashi T.

Chemistry. 2015 Jun 26;21(27):9742-7. doi: 10.1002/chem.201500979. Epub 2015 May 28.

PMID:
26017569
27.

[Career exploration as related to self-efficacy and the motivation based on self-determination theory].

Yoshizaki S, Hiraoka K.

Shinrigaku Kenkyu. 2015 Apr;86(1):55-61. Japanese.

PMID:
26012265
28.

Epidemiological and genetic analysis of a 2014 outbreak of hepatitis A in Japan.

Ishii K, Kiyohara T, Yoshizaki S, Kawabata K, Kanayama A, Yahata Y, Takahashi T, Kinoshita H, Saitou T, Sunagawa T, Oishi K, Uema M, Noda M, Wakita T.

Vaccine. 2015 Nov 9;33(45):6029-36. doi: 10.1016/j.vaccine.2015.04.061. Epub 2015 May 6.

PMID:
25957664
29.

Generation of hepatitis E virus-like particles of two new genotypes G5 and G6 and comparison of antigenic properties with those of known genotypes.

Li TC, Kataoka M, Takahashi K, Yoshizaki S, Kato T, Ishii K, Takeda N, Mishiro S, Wakita T.

Vet Microbiol. 2015 Jul 9;178(1-2):150-7. doi: 10.1016/j.vetmic.2015.04.020. Epub 2015 Apr 24.

PMID:
25934534
30.

Monkeys and Rats Are Not Susceptible to Ferret Hepatitis E Virus Infection.

Li TC, Yoshizaki S, Ami Y, Suzaki Y, Yang T, Takeda N, Takaji W.

Intervirology. 2015;58(3):139-42. doi: 10.1159/000373891. Epub 2015 Apr 30.

31.

Construction and characterization of an infectious cDNA clone of rat hepatitis E virus.

Li TC, Yang T, Yoshizaki S, Ami Y, Suzaki Y, Ishii K, Haga K, Nakamura T, Ochiai S, Takaji W, Johne R.

J Gen Virol. 2015 Jun;96(Pt 6):1320-7. doi: 10.1099/vir.0.000072. Epub 2015 Jan 29.

PMID:
25634930
32.

Establishment of hepatitis E virus infection-permissive and -non-permissive human hepatoma PLC/PRF/5 subclones.

Shiota T, Li TC, Yoshizaki S, Kato T, Wakita T, Ishii K.

Microbiol Immunol. 2015 Feb;59(2):89-94. doi: 10.1111/1348-0421.12219.

33.

Immunogenic modulation of cholangiocarcinoma cells by chemoimmunotherapy.

Koido S, Kan S, Yoshida K, Yoshizaki S, Takakura K, Namiki Y, Tsukinaga S, Odahara S, Kajihara M, Okamoto M, Ito M, Yusa S, Gong J, Sugiyama H, Ohkusa T, Homma S, Tajiri H.

Anticancer Res. 2014 Nov;34(11):6353-61.

PMID:
25368235
34.

Genome-wide evidence of positive selection in Bacteroides fragilis.

Yoshizaki S, Umemura T, Tanaka K, Watanabe K, Hayashi M, Muto Y.

Comput Biol Chem. 2014 Oct;52:43-50. doi: 10.1016/j.compbiolchem.2014.09.001. Epub 2014 Sep 6.

PMID:
25215651
35.

Apoptosis of antigen-specific CTLs contributes to low immune response in gut-associated lymphoid tissue post vaccination.

Shimada M, Yoshizaki S, Ichino M, Klinman DM, Okuda K.

Vaccine. 2014 Sep 8;32(40):5198-205. doi: 10.1016/j.vaccine.2014.07.046. Epub 2014 Jul 25.

36.

Treatment with chemotherapy and dendritic cells pulsed with multiple Wilms' tumor 1 (WT1)-specific MHC class I/II-restricted epitopes for pancreatic cancer.

Koido S, Homma S, Okamoto M, Takakura K, Mori M, Yoshizaki S, Tsukinaga S, Odahara S, Koyama S, Imazu H, Uchiyama K, Kajihara M, Arakawa H, Misawa T, Toyama Y, Yanagisawa S, Ikegami M, Kan S, Hayashi K, Komita H, Kamata Y, Ito M, Ishidao T, Yusa S, Shimodaira S, Gong J, Sugiyama H, Ohkusa T, Tajiri H.

Clin Cancer Res. 2014 Aug 15;20(16):4228-39. doi: 10.1158/1078-0432.CCR-14-0314. Epub 2014 Jul 23.

37.

Molecular detection of hepatitis E virus in rivers in the Philippines.

Li TC, Yang T, Shiota T, Yoshizaki S, Yoshida H, Saito M, Imagawa T, Malbas FF, Lupisan SP, Oshitani H, Wakita T, Ishii K.

Am J Trop Med Hyg. 2014 Apr;90(4):764-6. doi: 10.4269/ajtmh.13-0562. Epub 2014 Mar 3.

38.

The hepatitis E virus capsid C-terminal region is essential for the viral life cycle: implication for viral genome encapsidation and particle stabilization.

Shiota T, Li TC, Yoshizaki S, Kato T, Wakita T, Ishii K.

J Virol. 2013 May;87(10):6031-6. doi: 10.1128/JVI.00444-13. Epub 2013 Mar 6.

39.

Susceptibility of laboratory rats against genotypes 1, 3, 4, and rat hepatitis E viruses.

Li TC, Yoshizaki S, Ami Y, Suzaki Y, Yasuda SP, Yoshimatsu K, Arikawa J, Takeda N, Wakita T.

Vet Microbiol. 2013 Apr 12;163(1-2):54-61. doi: 10.1016/j.vetmic.2012.12.014. Epub 2012 Dec 26.

PMID:
23317806
40.

Epidemiological and genetic analyses of a diffuse outbreak of hepatitis A in Japan, 2010.

Ishii K, Kiyohara T, Yoshizaki S, Wakita T, Shimada T, Nakamura N, Nakashima K, Tada Y, Noda M.

J Clin Virol. 2012 Jul;54(3):286. doi: 10.1016/j.jcv.2012.04.002. Epub 2012 May 3. No abstract available.

PMID:
22560052
41.

Long-Term Persistent GBV-B Infection and Development of a Chronic and Progressive Hepatitis C-Like Disease in Marmosets.

Iwasaki Y, Mori K, Ishii K, Maki N, Iijima S, Yoshida T, Okabayashi S, Katakai Y, Lee YJ, Saito A, Fukai H, Kimura N, Ageyama N, Yoshizaki S, Suzuki T, Yasutomi Y, Miyamura T, Kannagi M, Akari H.

Front Microbiol. 2011 Dec 7;2:240. doi: 10.3389/fmicb.2011.00240. eCollection 2011.

42.

Immunogenic comparison of chimeric adenovirus 5/35 vector carrying optimized human immunodeficiency virus clade C genes and various promoters.

Shoji M, Yoshizaki S, Mizuguchi H, Okuda K, Shimada M.

PLoS One. 2012;7(1):e30302. doi: 10.1371/journal.pone.0030302. Epub 2012 Jan 19.

43.

Epidemiological and genetic analyses of a diffuse outbreak of hepatitis A in Japan, 2010.

Ishii K, Kiyohara T, Yoshizaki S, Wakita T, Shimada T, Nakamura N, Nakashima K, Tada Y, Noda M.

J Clin Virol. 2012 Mar;53(3):219-24. doi: 10.1016/j.jcv.2011.11.008. Epub 2011 Dec 22.

PMID:
22196871
44.

Vaccination with Human Induced Pluripotent Stem Cells Creates an Antigen-Specific Immune Response Against HIV-1 gp160.

Yoshizaki S, Nishi M, Kondo A, Kojima Y, Yamamoto N, Ryo A.

Front Microbiol. 2011 Feb 22;2:27. doi: 10.3389/fmicb.2011.00004. eCollection 2011.

45.

[The current status of nausea, vomiting and food intake in outpatients with cancer chemotherapy].

Nishi K, Kurokawa K, Hara J, Demura Y, Fujikawa N, Nikko Y, Yoshizaki S, Yamada C.

Gan To Kagaku Ryoho. 2011 Apr;38(4):607-11. Japanese.

PMID:
21498989
46.

Stimulation of human butyrophilin 3 molecules results in negative regulation of cellular immunity.

Yamashiro H, Yoshizaki S, Tadaki T, Egawa K, Seo N.

J Leukoc Biol. 2010 Oct;88(4):757-67. doi: 10.1189/jlb.0309156. Epub 2010 Jul 7.

PMID:
20610803
47.

DNA vaccine expressing HIV-1 gp120/immunoglobulin fusion protein enhances cellular immunity.

Shimada M, Yoshizaki S, Jounai N, Kondo A, Ichino M, Ryo A, Okuda K.

Vaccine. 2010 Jul 12;28(31):4920-7. doi: 10.1016/j.vaccine.2010.05.035. Epub 2010 Jun 3.

PMID:
20566393
48.

Co-administration of viral vector-based vaccines suppresses antigen-specific effector CD8 T cells.

Yashima S, Yoshizaki S, Shinoda K, Yoshida A, Kondo A, Mizuguchi H, Ryo A, Okuda K, Shimada M.

Vaccine. 2010 Apr 19;28(18):3257-64. doi: 10.1016/j.vaccine.2010.01.065. Epub 2010 Feb 25.

PMID:
20188679
49.

Partial protection against SIV challenge by vaccination of adenovirus and MVA vectors in rhesus monkeys.

Wang HB, Kondo A, Yoshida A, Yoshizaki S, Abe S, Bao LL, Mizuki N, Ichino M, Klinman D, Okuda K, Shimada M.

Gene Ther. 2010 Jan;17(1):4-13. doi: 10.1038/gt.2009.122. Epub 2009 Sep 17.

PMID:
19759567
50.

Adenovirus type 5 with modified hexons induces robust transgene-specific immune responses in mice with pre-existing immunity against adenovirus type 5.

Abe S, Okuda K, Ura T, Kondo A, Yoshida A, Yoshizaki S, Mizuguchi H, Klinman D, Shimada M.

J Gene Med. 2009 Jul;11(7):570-9. doi: 10.1002/jgm.1332.

PMID:
19391169

Supplemental Content

Loading ...
Support Center